GeneBioTech Co. Ltd (086060) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.004x

Based on the latest financial reports, GeneBioTech Co. Ltd (086060) has a cash flow conversion efficiency ratio of -0.004x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-230.73 Million ≈ $-156.36K USD) by net assets (₩56.25 Billion ≈ $38.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 086060 stock market capitalisation for the company's overall valuation and market capitalisation.

GeneBioTech Co. Ltd - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how GeneBioTech Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GeneBioTech Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GeneBioTech Co. Ltd ranked by their cash flow conversion efficiency. Explore GeneBioTech Co. Ltd (086060) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Siab Holdings Bhd KLSE:0241	0.563x
Bergen Carbon Solutions A/S OL:BCS	-0.198x
CryoCell International Inc NYSE MKT:CCEL	-0.171x
Hudson Acquisition I Corp. Common Stock NASDAQ:HUDA	0.012x
Q-Gold Resources Ltd V:QGR	0.311x
BayWa Aktiengesellschaft F:BYW	-0.099x
Amanah Leasing Public Company Limited BK:AMANAH	0.038x
Inderes Oyj HE:INDERES	0.074x

Annual Cash Flow Conversion Efficiency for GeneBioTech Co. Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of GeneBioTech Co. Ltd from 2009 to 2025. View 086060 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩55.00 Billion ≈ $37.27 Million	₩7.61 Billion ≈ $5.16 Million	0.138x	+1621.35%
2024-12-31	₩50.97 Billion ≈ $34.54 Million	₩-463.87 Million ≈ $-314.36K	-0.009x	-105.97%
2023-12-31	₩48.30 Billion ≈ $32.74 Million	₩7.37 Billion ≈ $4.99 Million	0.153x	+289.60%
2022-12-31	₩45.73 Billion ≈ $30.99 Million	₩-3.68 Billion ≈ $-2.49 Million	-0.080x	-24.45%
2021-12-31	₩43.95 Billion ≈ $29.78 Million	₩-2.84 Billion ≈ $-1.93 Million	-0.065x	-216.88%
2020-12-31	₩45.04 Billion ≈ $30.52 Million	₩2.49 Billion ≈ $1.69 Million	0.055x	+196.80%
2019-12-31	₩46.93 Billion ≈ $31.80 Million	₩-2.68 Billion ≈ $-1.82 Million	-0.057x	-146.02%
2018-12-31	₩47.96 Billion ≈ $32.50 Million	₩5.96 Billion ≈ $4.04 Million	0.124x	+343.93%
2017-12-31	₩40.49 Billion ≈ $27.44 Million	₩1.13 Billion ≈ $767.40K	0.028x	-79.46%
2016-12-31	₩39.02 Billion ≈ $26.44 Million	₩5.31 Billion ≈ $3.60 Million	0.136x	+50.66%
2015-12-31	₩28.84 Billion ≈ $19.54 Million	₩2.61 Billion ≈ $1.77 Million	0.090x	-1.78%
2014-12-31	₩23.42 Billion ≈ $15.87 Million	₩2.15 Billion ≈ $1.46 Million	0.092x	-10.63%
2013-12-31	₩23.10 Billion ≈ $15.65 Million	₩2.38 Billion ≈ $1.61 Million	0.103x	-20.67%
2011-12-31	₩19.48 Billion ≈ $13.20 Million	₩2.53 Billion ≈ $1.71 Million	0.130x	+104.69%
2010-12-31	₩18.38 Billion ≈ $12.45 Million	₩1.17 Billion ≈ $789.56K	0.063x	-57.24%
2009-12-31	₩18.08 Billion ≈ $12.25 Million	₩2.68 Billion ≈ $1.82 Million	0.148x	--

About GeneBioTech Co. Ltd

KQ:086060 Korea Pharmaceuticals

Market Cap

$27.34 Million

₩40.35 Billion KRW

Market Cap Rank

#24175 Global

#1705 in Korea

Share Price

₩4820.00

Change (1 day)

+3.10%

52-Week Range

₩3600.00 - ₩5230.00

All Time High

₩10031.60